SCHEMBL29634110

SCHEMBL29634110

C[C@H](CCCC(C)(O)C(O)(O)O)[C@H]1CC[C@H]2[C@@H]3CCC4CCCC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHA2 P29317 3/20 0.66
▸ GPBAR1 Q8TDU6 3/20 0.66
▸ HSD17B10 Q99714 3/20 0.66
▸ TDP1 Q9NUW8 3/20 0.66
▸ AKR1B10 O60218 2/20 0.66
▸ AKR1B1 P15121 2/20 0.66
▸ LMNA P02545 2/20 0.66
▸ EFNA1 P20827 1/20 0.66
▸ PSEN1 P49768 1/20 0.66
▸ PSEN2 P49810 1/20 0.66
▸ APH1B Q8WW43 1/20 0.66
▸ NCSTN Q92542 1/20 0.66
▸ APH1A Q96BI3 1/20 0.66
▸ PSENEN Q9NZ42 1/20 0.66
▸ MEN1 O00255 1/20 0.66
▸ KMT2A Q03164 1/20 0.66
▸ OSBP P22059 1/20 0.63
▸ OSBP2 Q969R2 1/20 0.63
▸ GRIN1 Q05586 1/20 0.56
▸ GRIN2A Q12879 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28512250 1.00 EPHA2 (0.66) EPHA2GPBAR1HSD17B10TDP1AKR1B10
SCHEMBL11571094 0.91 OSBP (0.75) EPHA2GPBAR1HSD17B10TDP1AKR1B10
SCHEMBL11785013 0.91 OSBP (0.75) EPHA2GPBAR1HSD17B10TDP1AKR1B10
SCHEMBL28731645 0.91 OSBP (0.75) EPHA2GPBAR1HSD17B10TDP1AKR1B10
SCHEMBL11524136 0.91 OSBP (0.75) EPHA2GPBAR1HSD17B10TDP1AKR1B10
SCHEMBL28529381 0.88 EPHA2 (0.64) EPHA2GPBAR1HSD17B10TDP1AKR1B10
SCHEMBL27660232 0.88 EPHA2 (0.64) EPHA2GPBAR1HSD17B10TDP1AKR1B10
SCHEMBL28222292 0.87 GPBAR1 (0.71) EPHA2GPBAR1HSD17B10TDP1AKR1B10
SCHEMBL7528751 0.87 GPBAR1 (0.71) EPHA2GPBAR1HSD17B10TDP1AKR1B10
SCHEMBL15353571 0.86 GPBAR1 (0.67) EPHA2GPBAR1HSD17B10TDP1AKR1B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3593143-B1 A SCREENING METHOD FOR CEREBROTENDINOUS XANTHOMATOSIS USING BILE ALCOHOL GLUCURONIDES AND METABOLITE RATIOS Stichting Amsterdam UMC (NL) 2024-11-27 — — EP claimed
CN-110612448-B Method for screening for xanthomatosis of brain tendons using ratio of bile alcohol glucuronide and metabolite 阿姆斯特丹大学学术医学中心 2023-06-13 — — CN claimed
US-11650212-B2 Screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios ACADEMISCH MEDISCH CENTRUM (NL) 2023-05-16 — — US claimed
EP-4219735-B1 METHOD AND APPARATUS FOR ANALYTE DETECTION USING AN ELECTROCHEMICAL BIOSENSOR ABBOTT DIABETES CARE (US) 2026-04-01 — — EP disclosed
EP-4538692-A2 METHOD AND APPARATUS FOR ANALYTE DETECTION USING AN ELECTROCHEMICAL BIOSENSOR Abbott Diabetes Care (US) 2025-04-16 — — EP disclosed
EP-3593143-B1 A SCREENING METHOD FOR CEREBROTENDINOUS XANTHOMATOSIS USING BILE ALCOHOL GLUCURONIDES AND METABOLITE RATIOS Stichting Amsterdam UMC (NL) 2024-11-27 — — EP disclosed
CN-118483297-A Method and apparatus for analyte detection using electrochemical biosensors 雅培糖尿病护理公司 2024-08-13 — — CN disclosed
CN-110799651-B Method and apparatus for analyte detection using electrochemical biosensors 雅培糖尿病护理公司 2024-05-24 — — CN disclosed
US-11753222-B2 Powdered pouch and method of making same MONOSOL, LLC (US) 2023-09-12 — — US disclosed
EP-4219735-A1 METHOD AND APPARATUS FOR ANALYTE DETECTION USING AN ELECTROCHEMICAL BIOSENSOR Abbott Diabetes Care (US) 2023-08-02 — — EP disclosed
CN-110612448-B Method for screening for xanthomatosis of brain tendons using ratio of bile alcohol glucuronide and metabolite 阿姆斯特丹大学学术医学中心 2023-06-13 — — CN disclosed
US-20230159979-A1 TRANSDUCERS, NANOPARTICLE TRANSDUCER DEVICES AND SYSTEMS, AND RELATED METHODS OF USE UNIVERSITY OF WASHINGTON (US) 2023-05-25 — — US disclosed
US-11650212-B2 Screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios ACADEMISCH MEDISCH CENTRUM (NL) 2023-05-16 — — US disclosed
EP-3645733-B1 METHOD AND APPARATUS FOR ANALYTE DETECTION USING AN ELECTROCHEMICAL BIOSENSOR ABBOTT DIABETES CARE (US) 2023-04-26 — — EP disclosed
EP-4135579-A1 TRANSDUCERS, NANOPARTICLE TRANSDUCER DEVICES AND SYSTEMS, AND RELATED METHODS OF USE University of Washington (US) 2023-02-22 — — EP disclosed
CN-115484867-A Transducer, nanoparticle transducer apparatus and system, and related methods of use 华盛顿大学 2022-12-16 — — CN disclosed
US-20220260517-A1 METHOD AND APPARATUS FOR ANALYTE DETECTION USING AN ELECTROCHEMICAL BIOSENSOR ABBOTT DIABETES CARE INC. 2022-08-18 — — US disclosed
EP-2825624-B2 WATER SOLUBLE COMPOSITIONS INCORPORATING ENZYMES, AND METHOD OF MAKING SAME MONOSOL LLC (US) 2022-07-27 — — EP disclosed
EP-2838811-B2 POWDERED POUCH AND METHOD OF MAKING SAME MONOSOL LLC (US) 2022-06-29 — — EP disclosed
US-11371957-B2 Method and apparatus for analyte detection using an electrochemical biosensor ABBOTT DIABETES CARE INC. (US) 2022-06-28 — — US disclosed
Send feedback